2021

September 2021 

• Sanarentero Awarded Phase I STTR award $400,000 for National Cancer Institute to Develop Drug Detoxifying Bacteria to Prevent Chemotherapy-induced Diarrhea.

​

August 2021

• Sanarentero in UH Technology Bridge News

​

February 2021

• Sanarentero participated in NIH-funded I-corps Program Feb Cohort for customer discovery and business development of Proprietary Botanical to Prevent Irinotecan-induced Diarrhea.

​

2020

September 2020

• Sanarentero Awarded Phase I SBIR award $325,000 for National Center for Complementary and Integrative Health to Develop Proprietary Botanical to Prevent Irinotecan-induced Diarrhea